| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8957262 | The Journal of Heart and Lung Transplantation | 2018 | 21 Pages |
Abstract
The increase in serum VEGF before onset of detectable CAV is fundamental to its utility as a predictive biomarker and suggests further investigations of VEGF in the pathogenesis of CAV are warranted in the pediatric heart transplant population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kae MD, Anis PhD, Alix BS, Shelley D. MD, Stephanie J. MD,